While authorities around the world are tracking down potential cases following the outbreak on the cruise ship Hondius, work is now underway to develop a new vaccine against hantavirus. At the same time, criticism is mounting over how quickly vaccination campaigns and infection control measures are once again taking center stage.
An international research team is currently working to develop a new vaccine against hantavirus following the deaths linked to Hondius. The project is being led in part by the University of Bath, and the vaccine has already been tested in the laboratory and on animals, reports Daily Mail.
This article is part of our exclusive premium content
- For Frihetsnytt subscribers only.
At Frihetsnytt, we rely entirely on you, our readers. Without government subsidies, without major advertisers, and without political agendas, we can uncover the facts, hold those in power accountable, and tell the truth—just as it is. Join our community today and get immediate access to all locked articles, exclusive interviews, podcasts, and events.
Try it for 14 days completely free—no commitment. After that, starting at just 69 SEK/month (billed annually).
Together, we’re building Sweden’s strongest independent media company. Welcome!
